InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| pFUSE-CHIg-hG1 | High-content analysis of antibody phage-display library selection outputs ide... | 2016 | Mol Cell Proteomics. | Ha K.D. et al. | DOI: 10.1074/mcp.M114.039768 |
| c-di-GMP | The ER-Associated Protein ZDHHC1 Is a Positive Regulator of DNA Virus-Trigger... | 2014 | Cell Host Microbe. | Zhou Q. et al. | DOI: 10.1016/j.chom.2014.09.006 |
| FLA-ST (Standard or Ultrapure) | Identification of adjuvantic activity of Amphotericin B in a novel, multiplex... | 2016 | PLoS One. | Salyer A.C. et al. | DOI: 10.1371/journal.pone.0149848 |
| Anti-CD20 (Rituximab biosimilar - IgA2 isotype) | Engineered SIRPα variants as immunotherapeutic adjuvants to anticancer antibo... | 2013 | Science. | Weiskopf K. et al. | 341(6141):88-91. |
| ODN 1826 - TLR9 ligand | Injectable, spontaneously assembling, inorganic scaffolds modulate immune cel... | 2015 | Nat Biotechnol. | Kim J. et al. | DOI: 10.1038/nbt.3071 |
| Pam3CSK4 | Cell based assay identifies TLR2 and TLR4 stimulating impurities in Interfero... | 2017 | Sci Rep. | Haile L.A. et al. | DOI: 10.1038/s41598-017-09981-w |
| NLRP3 KO & KD THP-1 Cells | Enhanced Immune Adjuvant Activity of Aluminum Oxyhydroxide Nanorods through C... | 2017 | ACS Appl Mater Interfaces. | Sun B. et al. | DOI: 10.1021/acsami.7b05817 |
| RAW-Blue™ Cells | S100B promotes glioma growth through chemoattraction of myeloid-derived macro... | 2013 | Clin Cancer Res. | Wang H. et al. | DOI: 10.1158/1078-0432.CCR-12-3725 |
| Pam3CSK4 | Type III IFNs Are Commonly Induced by Bacteria-Sensing TLRs and Reinforce Epi... | 2017 | J Immunol. | Odendall C. et al. | DOI: 10.4049/jimmunol.1700250 |
| NLRP3 KO & KD THP-1 Cells | Potent NLRP3 inflammasome activation by the HIV reverse-transcriptase inhibit... | 2017 | J Biol Chem. | Toksoy A. et al. | DOI: 10.1074/jbc.M116.749473 |
| pCpGfree-vitro Blasticidin | CDK9-mediated transcription elongation is required for MYC addiction in hepat... | 2014 | Genes Dev. | Huang C.H. et al. | DOI: 10.1101/gad.244368.114 |
| LPS-PG (Lipopolysaccharide from P. gingivalis) | Identification and functional characterization of a new IL-1 family member, I... | 2014 | Innate Immun. | Angosto D. et al. | DOI: 10.1177/1753425913501011 |
| N-Glycolyl-MDP | HIV Envelope Trimer Specific Immune Response Is Influenced by Different Adjuv... | 2016 | PLoS One. | Apostólico Jde S. et al. | DOI: 10.1371/journal.pone.0145637 |
| IL-1α & IL-1β Reporter HEK 293 Cells | Caspase-8 as an effector and regulator of NLRP3 inflammasome signaling. | 2015 | J Biol Chem. | Antonopoulos C. et al. | DOI: 10.1074/jbc.M115.652321 |
| CL264 | Cutting Edge: Endogenous IFN-β Regulates Survival and Development of Transiti... | 2017 | J Immunol. | Hamilton J.A. et al. | DOI: 10.4049/jimmunol.1700888 |
| ODN 1826 control (ODN 2138) | Stimulation and inhibition of FVIII-specific memory B-cell responses by CpG-B... | 2011 | Blood | Allacher P. et al. | DOI: 10.1182/blood-2010-06-289009 |
| ODN 1585 - TLR9 ligand | Type 1 Interferons Induce Changes in Core Metabolism that Are Critical for Im... | 2016 | Immunity. | Wu D. et al. | DOI: 10.1016/j.immuni.2016.06.006 |
| THP1-Blue™ ISG Cells | THP-1 cell line: An in vitro cell model for immune modulation approach. | 2014 | Int Immunopharmacol. | Chanput W. et al. | DOI: 10.1016/j.intimp.2014.08.002 |
| 293/Control Cells | Cleaved/Associated TLR3 Represents the Primary Form of the Signaling Receptor. | 2013 | J Immunol. | Toscano F. et al. | DOI: 10.4049/jimmunol.1202173 |
| LTA-SA | Preconditioning with Lipopolysaccharide or Lipoteichoic Acid Protects against... | 2017 | Front Immunol. | Breyne K. et al. | DOI: 10.3389/fimmu.2017.00833 |